SCHEMBL10146697

SCHEMBL10146697

O=c1[nH]c2ccccc2c(-c2cccc(-c3cccnc3)c2)c1C1=CCCS1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FASN P49327 1/20 0.46
PADI4 Q9UM07 5/20 0.42
MAPK14 Q16539 2/20 0.40
CDK5 Q00535 2/20 0.40
CDK5R1 Q15078 2/20 0.40
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
GRIN2D O15399 2/20 0.39
GRIN3B O60391 2/20 0.39
GRIN1 Q05586 2/20 0.39
GRIN2A Q12879 2/20 0.39
GRIN2B Q13224 2/20 0.39
GRIN2C Q14957 2/20 0.39
GRIN3A Q8TCU5 2/20 0.39
CYP11B1 P15538 2/20 0.39
CYP11B2 P19099 2/20 0.39
PARP1 P09874 1/20 0.38
FLT3 P36888 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6351855 0.88 PADI4 (0.50) PADI4ALDH1A1
SCHEMBL6350424 0.88 MAPT (0.43) FASNPADI4MAPK14CDK5CDK5R1
SCHEMBL6352443 0.82 MAPK14 (0.43) PADI4MAPK14CDK5CDK5R1GRIN2D
SCHEMBL998426 0.78 PDE2A (0.52) FASNPADI4MAPK14CDK5CDK5R1
SCHEMBL6884723 0.74 FASN (0.40) FASNPADI4MAPK14CDK5CDK5R1
SCHEMBL6825080 0.70 MAPK14 (0.52) PADI4MAPK14CYP11B1CYP11B2PARP1
SCHEMBL932818 0.69 CYP2E1 (0.52) PADI4MAPK14CDK5CDK5R1KDM4E
SCHEMBL962621 0.68 PDE2A (0.55) MAPK14CDK5CDK5R1GRIN2DGRIN3B
SCHEMBL29455656 0.67 CYP2A6 (0.58) CDK5KDM4EALDH1A1CYP11B1CYP11B2
SCHEMBL17227623 0.67 CYP2A6 (0.58) CDK5KDM4EALDH1A1CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120115885-A1 Quinolinone PDE2 Inhibitors MERCK SHARP & DOHME LLC 2012-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120115885-A1 Quinolinone PDE2 Inhibitors PDE12, PDE2A, PDE4A FASN 3427/4885PADI4 494/4885MAPK14 2536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.